Evidence map›Paper›PMID 35497901›Full record

ArticlePharmacy practice

Knowledge, attitude, and practice of patients with diabetes towards diabetic nephropathy, neuropathy and retinopathy.

Nada Dia, Sara Ferekh, Stephanie Jabbour, Zeina Akiki, Mohamad Rahal, Maya Khoury, Marwan Akel

Open access · diamondAbstract read
In one paragraph

Article in Pharmacy practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Nada DiaPharmD, MSc. School of Pharmacy, Lebanese International University, Beirut, Lebanon. nadadia29@gmail.com.ORCID https://orcid.org/0000-0003-1818-1949
Sara FerekhPharmD. School of Pharmacy, Lebanese International University, Beirut, Lebanon. 11330575@students.liu.edu.lb.
Stephanie JabbourPharmD. School of Pharmacy, Lebanese International University, Beirut, Lebanon. jabbourstephanie@hotmail.com.
Zeina AkikiPhD. School of Pharmacy, Lebanese International University, Beirut, INSPECT-LB: Institut National de Santé Publique, Épidémiologie Clinique et Toxicologie - Liban, Beirut, Lebanon. zeina.akiki@liu.edu.lb.ORCID https://orcid.org/0000-0001-6010-0909
Mohamad RahalPhD. School of Pharmacy, Lebanese International University, Beirut, Lebanon. Mohamad.rahal@liu.edu.lb.ORCID https://orcid.org/0000-0002-9707-6217
Maya KhouryPharmD. School of Pharmacy, Lebanese International University, Beirut, Lebanon. Maya.Khoury@liu.edu.lb.
Marwan AkelPharmD, MPH, PhD. School of Pharmacy, Lebanese International University, Beirut, INSPECT-LB: Institut National de Santé Publique, Épidémiologie Clinique et Toxicologie - Liban, Beirut, Lebanon. Marwan.Akel@liu.edu.lb.ORCID https://orcid.org/0000-0002-1419-2934
Lebanese International University · LBInstitut National de Santé Publique · GN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Epidemiological and knowledge, attitude and practice (KAP) studies about diabetic microvascular complications are lacking. The goals of this study are: determining 1) the prevalence of diabetes mellitus subtypes and microvascular complications, 2) the KAP towards the complications and 3) health-seeking behavior, barriers to follow-up, stigma and sources of information. Methods: A cross-sectional study was conducted from January to October 2020 enrolling 380 Lebanese patients with diabetes asked about socio-demographic and lifestyle characteristics, medical, therapeutic, supplement, and dietary history, KAP scores, health-seeking behavior, stigma, barriers to compliance, and sources of information. Results: The prevalence of diabetes type II, type I, gestational, and the microvascular complications was 82.23%, 15.65%, 2.12%, and 33.07% respectively. Factors with significant association were: 1) good quality of life (β=-0.03; p=0.005) and presence of microvascular complications (β=3.58; p=0.001) with knowledge score, 2) good quality of life (β=-0.01; p=0.02) and absence of the complications (β=-0.33; p=0.001) with attitude score, 3) advanced age (β=0.01; p=0.01), no metformin (β=-0.39; p=0.005), and low-protein diet (β=0.6; p=0.02) with practice score. Patients visited community pharmacies (41.84%) and clinics (46.32%). Barriers were costs (33.42%) and time (30.53%). Few talked about the complications to the family (19.74%). Sources of information were healthcare workers. Conclusion: Awareness campaigns should be tailored accordingly to retard the microvascular complications.

Indexed as

AttitudeDiabetes mellitusKnowledgeMicrovascular complicationsPractice

Identifiers

PMID35497901
PMCPMC9014900
OpenAlexW4223607673

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.